---
title: "Genrix Bio: GR2303 injection has obtained the drug clinical trial approval notice"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/256344447.md"
description: "According to the Zhitong Finance APP, Genrix Bio announced that the company has recently received the \"Drug Clinical Trial Approval Notification\" issued by the National Medical Products Administration. The clinical trial application for the company's research product GR2303 injection has been approved, allowing the clinical trial for inflammatory bowel disease indications to proceed. As of the announcement date, there are no other drugs targeting the same indication as GR2303 injection approved for marketing in China"
datetime: "2025-09-08T08:48:05.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/256344447.md)
  - [en](https://longbridge.com/en/news/256344447.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/256344447.md)
generator: "portal-rs"
---

# Genrix Bio: GR2303 injection has obtained the drug clinical trial approval notice

According to the Zhitong Finance APP, Genrix Bio (688443.SH) announced that it has recently received the "Drug Clinical Trial Approval Notice" issued by the National Medical Products Administration. The clinical trial application for the company's investigational product GR2303 injection has been approved, allowing the clinical trial for the indication of inflammatory bowel disease to proceed.

As of the announcement date, there are no drugs targeting the same indication as GR2303 injection approved for marketing in China

### Related Stocks

- [688443.CN](https://longbridge.com/en/quote/688443.CN.md)

## Related News & Research

- [Trump Wants Beef Prices to Come Down, But GOP Congressman Warns Washington's Import Push Could Pull the ‘Rug Out’ From Ranchers](https://longbridge.com/en/news/297776718.md)
- [Bengaluru-based Sales Intelligence Startup Overlayy Becomes a Part of Benchmark-backed Monaco](https://longbridge.com/en/news/298064856.md)
- [Patient enrolment concludes in Senhwa’s Phase Ib trial of pidnarulex](https://longbridge.com/en/news/298029888.md)
- [RCS - Dynex Quantum Tech. - Canopy Height Prediction: Faster & 90% Lower Cost](https://longbridge.com/en/news/298054229.md)
- [Uniao Pet Participacoes: Grupo Petz Cobasi drives growth in Brazil's booming pet market with omnichannel leadership and synergy gains](https://longbridge.com/en/news/297552330.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**